InvestorsHub Logo
Followers 2
Posts 19
Boards Moderated 0
Alias Born 12/16/2013

Re: snow54 post# 18487

Wednesday, 03/19/2014 11:59:48 PM

Wednesday, March 19, 2014 11:59:48 PM

Post# of 144814
I believe that this information is true .......

Anyone know if it is true?

I found this information on yahoo finance forum is true?

Sue is correct the fda gave NVLX the go ahead here its right here for all to read.
In one study led by researchers at St George's, University of London, and published in Anticancer Research in late 2013, scientists studying six different cannabinoids found that each possessed anti-cancer properties similar to those observed with THC, and further, that the positive effect of cannabinoids on in leukemia cancer cells increased when they were combined with other cannabis-derived compounds.

In November 2013 the FDA gave Nuvilex Inc. and its subsidiary MM Sciences, sponsors of the University of London study, permission to begin clinical trials of CBD. The approval appears to signify a shift in the level of support given to cannabis research by federal regulators.

According to the FDA, among the 60-some known cannabinoids found in cannabis, CBD is the second most abundant (after THC) and offers therapeutic benefits without the "high" which can be psychologically disturbing for some individuals or lead to addictions in others.

As more states approve the use of #$%$” for pain management and regulators express interest in the potential therapeutic benefit of cannabis in disease management, it's likely that cannabis research will also grow exponentially, and lead to a greater number of cannabis-based medicines reaching the marketplace over the next decade.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News